Procedure Guidelines for Lu-177 PSMA Radyoligand Treatment

Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 3

Abstract

Prostate-specific membrane antigen (PSMA) is expressed in most prostate cancers and PSMA-directed radioligand therapy (RLT) with Lutetium-177 (Lu-177) PSMA is promising systemic modality, which involves the delivery of targeted radiation therapy in the form of β-particles to sites of tumour tissue. Although, Lu-177 PSMA RLT has been recently introduced for castration-resistant metastatic prostate cancer (CRMPC), has continuously increasing interest and use in many centers. Therapy is well tolerated with relatively few side effects and has a positive effect on overall survival and quality of life. The purpose of this guideline is to assist nuclear medicine specialists in evaluating and managing patients with RCMPC for whom RLT using Lu-177 PSMA as an “unproven intervention in clinical practice”, in accordance with the best currently available knowledge.

Authors and Affiliations

İlknur Ak Sivrikoz, Gülin Uçmak, Gamze Kaya Çapa, Emre Demirci, Nalan Alan Selçuk, Cüneyt Türkmen, Umut Elboğa, Levent Kabasakal

Keywords

Related Articles

Oncologic Approaches for Bone Metastasis Related Pain

Bone is the third most common metastatic site after lungs and liver in advanced stages of cancer. Bone pain may be caused by local compression and/or invasion of the tumor or a pathological fracture due to bone metastasi...

Iodine-123 Meta-iodobenzylguanidine Cardiac Innervation Imaging Guideline

Sympathetic innervation of the heart plays an important role in the pathophysiology of diseases, especially congestive heart failure and arrhythmias. Iodine-123 metaiodobenzylguanidine (I-123 MIBG) scintigraphy allows fo...

Procedure Guideline for Lymphoscintigraphy and Sentinel Lymph Node: Malignant Melanoma

Malignant melanoma is still among the most fatal cancers worldwide with increasing incidence. Lymphoscintigraphy and gamma probe guided sentinel lymph node detection is an established procedure which has a great impact i...

Guideline for PET/CT Imaging of Neuroendocrine Neoplasms with 68Ga-DOTA-conjugated Somatostatin Receptor Targeting Peptides

Neuroendocrine tumors (NETs) are one of the rare cancers that have been increasing in recent years. The importance of Ga-68 DOTA-Conjugated Peptides Receptor imaging has been reported in many retrospective and prospectiv...

Early and Late Side Effects and Patient Management in I-131 Treatment

I-131 is the first most experienced theranostic radionuclide that has been used since the early 1940s for the treatment of hyperthyroidism, metastases or ablation of residual thyroid tissue in well-differentiated thyroid...

Download PDF file
  • EP ID EP691580
  • DOI 10.4274/nts.galenos.2020.0031
  • Views 115
  • Downloads 0

How To Cite

İlknur Ak Sivrikoz, Gülin Uçmak, Gamze Kaya Çapa, Emre Demirci, Nalan Alan Selçuk, Cüneyt Türkmen, Umut Elboğa, Levent Kabasakal (2020). Procedure Guidelines for Lu-177 PSMA Radyoligand Treatment. Nuclear Medicine Seminars, 6(3), -. https://www.europub.co.uk/articles/-A-691580